Drug Profile
Mutant somatropin - JCR Pharmaceutical
Alternative Names: Mutant growth hormoneLatest Information Update: 15 Aug 2002
Price :
$50
*
At a glance
- Originator JCR Pharmaceuticals
- Class Hormones
- Mechanism of Action Somatotropin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acromegaly
Most Recent Events
- 18 Apr 1997 New profile
- 18 Apr 1997 Preclinical development for Acromegaly in Japan (Unknown route)